A website which contained outdated information about the risk of using hormone replacement therapy has been found in breach of …
Pharmaceutical companies in the UK will have to declare the amount of money paid to its healthcare professionals who act …
Astellas has been the subject of ‘naming and shaming’ advertisements in three medical journals after advisory board meetings it ran …

The UK’s Code of Practice regulator will produce guidance for pharma on digital marketing, but is reluctant to make formal …
Three UK pharma companies have been ‘named and shamed’ for serious breaches of the ABPI’s Code of Practice. Solvay, Pfizer …
Ferring Pharmaceuticals and Stiefel Laboratories have been named and shamed for breaching the ABPI Code of Practice. Adverts giving details …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

